Association between the Interleukin-17A -197G>A (rs2275913) Polymorphism and Risk of Digestive Cancer |
Duan, Yin
(Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, School of Medicine, Zhejiang University)
Shi, Ji-Nan (Department of Medical Oncology, Zhejiang Hospital) Pan, Chi (Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, School of Medicine, Zhejiang University) Chen, Hai-Long (Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, School of Medicine, Zhejiang University) Zhang, Su-Zhan (Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, School of Medicine, Zhejiang University) |
1 | Arisawa T, Tahara T, Shiroeda H, et al (2012). Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3'-UTR, influence susceptibility to gastric cancer. Hum Immunol, 73, 747-52. DOI |
2 | Bazzi MD, Sultan MA, Al Tassan N, et al (2011). Interleukin 17A and F and asthma in Saudi Arabia: gene polymorphisms and protein levels. J Investig Allergol Clin Immunol, 21, 551-5. |
3 | Bettelli E, Carrier Y, Gao W, et al (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 441, 235-8. DOI ScienceOn |
4 | Bidwell J, Keen L, Gallagher G, et al (1999). Cytokine gene polymorphism in human disease: on-line databases. Genes Immun, 1, 3-19. DOI ScienceOn |
5 | Bredberg A (2011). Cancer: more of polygenic disease and less of multiple mutations? A quantitative viewpoint. Cancer, 117, 440-5. DOI |
6 | Breslow NE, Day NE (1987). Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ, 1-406. |
7 | Chen J, Deng Y, Zhao J, et al (2010). The polymorphism of IL-17 G-152A was associated with childhood asthma and bacterial colonization of the hypopharynx in bronchiolitis. J Clin Immunol, 30, 539-45. DOI |
8 | Dai W, Zhou Q, Tan X, et al (2014). IL-17A (-197G/A) and IL-17F (7488T/C) gene polymorphisms and cancer risk in Asian population: a meta-analysis. Onco Targets Ther, 7, 703-11. |
9 | DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. DOI ScienceOn |
10 | Doroudchi M, Pishe ZG, Malekzadeh M, et al (2013). Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma. Asian Pac J Cancer Prev, 14, 5225-30. 과학기술학회마을 DOI ScienceOn |
11 | Espinoza JL, Takami A, Nakata K, et al (2011). A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS One, 6, 26229. DOI |
12 | Gonzalez-Hormazabal P, Musleh M, Bustamante M, et al (2014). Role of cytokine gene polymorphisms in gastric cancer risk in Chile. Anticancer Res, 34, 3523-30. |
13 | Haber M (1981). Exact significance levels of goodness-of-fit tests for the Hardy-Weinberg equilibrium. Hum Hered, 31, 161-6. DOI |
14 | Harrington LE, Hatton RD, Mangan PR, et al (2005). Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol, 6, 1123-32. DOI ScienceOn |
15 | Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. DOI ScienceOn |
16 | Hoeijmakers JH (2001). Genome maintenance mechanisms for preventing cancer. Nature, 411, 366-74. DOI ScienceOn |
17 | Kaabachi W, ben Amor A, Kaabachi S, et al (2014). Interleukin-17A and -17F genes polymorphisms in lung cancer. Cytokine, 66, 23-9. DOI |
18 | Karin M (2006). Nuclear factor-kappaB in cancer development and progression. Nature, 441, 431-6. DOI ScienceOn |
19 | Kawaguchi M, Adachi M, Oda N, et al (2004). IL-17 cytokine family. J Allergy Clin Immunol, 114, 1265-73. DOI |
20 | Kato T, Furumoto H, Ogura T, et al (2001). Expression of IL-17 mRNA in ovarian cancer. Biochem Biophys Res Commun, 282, 735-8. DOI ScienceOn |
21 | Kolls JK, Linden A (2004). Interleukin-17 family members and inflammation. Immunity, 21, 467-76. DOI ScienceOn |
22 | Kuper H, Adami HO, Trichopoulos D (2000). Infections as a major preventable cause of human cancer. J Intern Med, 248, 171-83. DOI ScienceOn |
23 | Kutikhin AG, Yuzhalin AE, Volkov AN, et al (2014). Correlation between genetic polymorphisms within IL-1B and TLR4 genes and cancer risk in a Russian population: a case-control study. Tumour Biol, 35, 4821-30. DOI |
24 | Li N, Zhu Q, Li Z, et al (2014). IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Mol Carcinog, 53, 447-57. DOI |
25 | Lin WW, Karin M (2007). A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest, 117, 1175-83. DOI ScienceOn |
26 | Liu J, Duan Y, Cheng X, et al (2011). IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun, 407, 348-54. DOI |
27 | Liu XK, Lin X, Gaffen SL (2004). Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17. J Biol Chem, 279, 52762-71. DOI |
28 | Mustapha MA, Shahpudin SN, Aziz AA, et al (2012). Risk modification of colorectal cancer susceptibility by interleukin-8 -251T>A polymorphism in Malaysians. World J Gastroenterol, 18, 2668-73. DOI ScienceOn |
29 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
30 | Moseley TA, Haudenschild DR, Rose L, et al (2003). Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev, 14, 155-74. DOI ScienceOn |
31 | Numasaki M, Fukushi J, Ono M, et al (2003). Interleukin-17 promotes angiogenesis and tumor growth. Blood, 101, 2620-7. DOI ScienceOn |
32 | Omrane I, Marrakchi R, Baroudi O, et al (2014). Significant association between interleukin-17A polymorphism and colorectal cancer. Tumour Biol, 35, 6627-32. DOI |
33 | Pan XF, Yang SJ, Loh M, et al (2013). Interleukin-10 gene promoter polymorphisms and risk of gastric cancer in a Chinese population: single nucleotide and haplotype analyses. Asian Pac J Cancer Prev, 14, 2577-82. 과학기술학회마을 DOI ScienceOn |
34 | Qinghai Z, Yanying W, Yunfang C, et al (2014). Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population. Gene, 537, 328-32. DOI |
35 | Quan Y, Zhou B, Wang Y, et al (2012). Association between IL17 polymorphisms and risk of cervical cancer in Chinese women. Clin Dev Immunol, 2012, 258293. |
36 | Rafiei A, Hosseini V, Janbabai G, et al (2013). Polymorphism in the interleukin-17A promoter contributes to gastric cancer. World J Gastroenterol, 19, 5693-9. DOI |
37 | Wang M, Zhang Y, Han D, et al (2012). Association between polymorphisms in cytokine genes IL-17A and IL-17F and development of allergic rhinitis and comorbid asthma in Chinese subjects. Hum Immunol, 73, 647-53. DOI |
38 | Sterne JA, Gavaghan D, Egger M (2000). Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol, 53, 1119-29. DOI |
39 | Straus DS (2013). TNFalpha and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells. Mol Cancer, 12, 78. DOI |
40 | Wang L, Jiang Y, Zhang Y, et al (2012). Association analysis of IL-17A and IL-17F polymorphisms in Chinese Han women with breast cancer. PLoS One, 7, 34400. DOI |
41 | Wang N, Yang J, Lu J, et al (2014). IL-17 gene polymorphism is associated with susceptibility to gastric cancer. Tumour Biol. |
42 | Wang S, Liu Z, Wang L, et al (2009). NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol, 6, 327-34. DOI ScienceOn |
43 | Wu X, Zeng Z, Chen B, et al (2010). Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer. Int J Cancer, 127, 86-92. DOI |
44 | Wu X, Zeng Z, Xu L, et al (2014). Increased expression of IL17A in human gastric cancer and its potential roles in gastric carcinogenesis. Tumour Biol, 35, 5347-56. DOI |
45 | Yang L, Sun MJ, Liu JW, et al (2013). IL-6-6331 (T/C, rs10499563) is associated with decreased risk of gastric cancer in Northern Chinese. Asian Pac J Cancer Prev, 14, 7467-72. 과학기술학회마을 DOI |
46 | Zhang T, Wang H (2013). Variants of interleukin-16 associated with gastric cancer risk. Asian Pac J Cancer Prev, 14, 5269-73. 과학기술학회마을 DOI ScienceOn |
47 | Yin J, Wang L, Shi Y, et al (2014). Interleukin 17A rs4711998 A>G polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population. Dis Esophagus, 27, 87-92. DOI ScienceOn |
48 | Zhang B, Rong G, Wei H, et al (2008). The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun, 374, 533-7. DOI |
49 | Zhang GQ, Han F, Fang XZ, et al (2012). CD4+, IL17 and Foxp3 expression in different pTNM stages of operable non-small cell lung cancer and effects on disease prognosis. Asian Pac J Cancer Prev, 13, 3955-60. 과학기술학회마을 DOI ScienceOn |
50 | Zhao HY, Wang R, Ma W (2014). IL-17A G197A and IL-17F T7488C polymorphisms and cancer risk in Asian populations: a meta-analysis. J BUON, 19, 562-6. |
51 | Zhou B, Zhang P, Wang Y, et al (2013). Interleukin-17 gene polymorphisms are associated with bladder cancer in a Chinese Han population. Mol Carcinog, 52, 871-8. DOI |
52 | Zhu X, Mulcahy LA, Mohammed RA, et al (2008). IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res, 10, 95. |
53 | Alexandrakis MG, Pappa CA, Miyakis S, et al (2006). Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma. Eur J Intern Med, 17, 412-6. DOI |
![]() |